Live feed
Filing
SC 13D
SC 13D0001104659-20-120940·Addex Therapeutics Ltd.
Schedule 13D ownership disclosure
ADDEX THERAPEUTICS LTD
Security class unavailable · CUSIP: 00654J107
Event date: 2020-10-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,867,549
- Percent of class
- 8.7300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-120940
- Form type
- SC 13D
- Filer
- Addex Therapeutics Ltd.
- CIK
- CIK 1574232
- Filed
- Nov 03, 2020
- Reporting period
- Oct 25, 2020
- Description
- Schedule 13D beneficial ownership